SCHEMBL7145735

SCHEMBL7145735

O=C(c1ccc(Cl)cc1)C1C(=O)c2ccccc2C1=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.72
HTT P42858 4/20 0.72
HBB P68871 2/20 0.72
ALOX15 P16050 2/20 0.72
CYP2C9 P11712 2/20 0.69
CYP2C19 P33261 2/20 0.69
CYP1A2 P05177 1/20 0.69
RAB9A P51151 3/20 0.52
CES2 O00748 2/20 0.47
CES1 P23141 2/20 0.47
ALDH1A1 P00352 3/20 0.46
HSD17B10 Q99714 1/20 0.46
SLC25A5 P05141 2/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ADORA3 P0DMS8 1/20 0.43
THRB P10828 1/20 0.43
CHRM1 P11229 1/20 0.43
TBXA2R P21731 1/20 0.43
PTGS1 P23219 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11451081 0.84 MAPT (1.00) MAPTHTTHBBALOX15CYP2C9
SCHEMBL4811658 0.81 MAPT (0.72) MAPTHTTHBBALOX15CYP2C9
SCHEMBL6958511 0.81 MAPT (1.00) MAPTHTTHBBALOX15CYP2C9
SCHEMBL22802233 0.81 MAPT (0.61) MAPTHTTHBBALOX15CYP2C9
SCHEMBL29603379 0.81 MAPT (0.61) MAPTHTTHBBALOX15CYP2C9
SCHEMBL6863960 0.81 HTT (0.66) MAPTHTTHBBALOX15CYP2C9
SCHEMBL8604882 0.78 MAPT (0.72) MAPTHTTHBBALOX15CYP2C9
SCHEMBL6970354 0.77 MAPT (0.68) MAPTHTTHBBALOX15CYP2C9
Chlorophacinone SCHEMBL11577573 0.71 MEN1 (0.81) MAPTHTTHBBALOX15RAB9A
Chlorophacinone SCHEMBL4187624 0.71 MEN1 (0.81) MAPTHTTHBBALOX15RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534655-B1 Administering as anti-angiogenic compounds or to inhibit vascular hyperpermeability BASF AKTIENGESELLSCHAFT (DE) 2003-03-18 US disclosed
EP-1021182-A1 INDENO[1,2-C] PYRAZOLE DERIVATIVES FOR INHIBITING TYROSINE KINASE ACTIVITY BASF AKTIENGESELLSCHAFT (DE) 2000-07-26 EP disclosed
WO-1999017770-A1 INDENO[1,2-C]PYRAZOLE DERIVATIVES FOR INHIBITING TYROSINE KINASE ACTIVITY BASF AKTIENGESELLSCHAFT (DE) 1999-04-15 WO disclosed